Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (Cryptotis parva)
Temsirolimus is a prodrug form of sirolimus (rapamycin). With its analogs (everolimus, ridaforolimus, and rapamycin), it forms a group of anticancer agents that block the activity of one of the two mammalian targets of rapamycin (mTOR) complexes, mTORC1. We investigated the emetic potential of varyi...
Saved in:
Main Authors: | Louiza Belkacemi (Author), Yina Sun (Author), Nissar A. Darmani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis
by: Weixia Zhong, et al.
Published: (2021) -
The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew (Cryptotis parva)
by: W. Zhong, et al.
Published: (2021) -
Temsirolimus in the treatment of advanced renal cell carcinoma
by: Bernard J. Escudier
Published: (2011) -
Temsirolimus in the treatment of advanced renal cell carcinoma
by: Bernard J. Escudier
Published: (2011) -
Therapeutic Effect of Repurposed Temsirolimus in Lung Adenocarcinoma Model
by: Hsuen-Wen Chang, et al.
Published: (2018)